Journal article icon

Journal article

Improving Collaborative Engagement in Health State Valuation: A Scoping Review of Current Practices and Emerging Recommendations

Abstract:
Background and Objective Collaborative engagement with individuals invested in or affected by health research, beyond researchers themselves, is advantageous and encouraged by major funding bodies. However, the degree of collaborative engagement in health state valuation is unclear. A scoping review was conducted to (i) identify recommendations on best practice in collaborative engagement in health economics and related literature; (ii) identify examples of collaborative engagement in valuation studies; and (iii) map (ii) onto (i) to identify current practice and future recommendations. Methods Eight databases were searched in March-May 2024, with grey literature searches in August-September 2024. For objective (i), reports or manuscripts in health economics or patient-reported outcome measure development/evaluation of any date providing recommendations for collaborative engagement were included. For objective (ii), articles published since 2019 featuring health state valuation and collaborative engagement were included. Best practice recommendations were extracted and thematically synthesised. Examples of collaborative engagement were extracted and mapped against recommendations. Results Twenty-two records featuring recommendations and 15 valuation studies were included. A 15-item framework of emerging best practice recommendations for collaborative engagement was synthesised. Most examples of collaborative engagement involved patients and/or experts helping inform health states for valuation. There was no evidence for 9 out of 15 synthesised recommendations having been applied in any of the valuation studies and only minimal evidence was extracted for the remaining six. Conclusions Collaborative engagement in health state valuation is underdeveloped and unaligned with literature recommendations. A 15-point framework has been developed as a strategic starting point for developing guidance to improve practice in the field
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1007/s40273-025-01550-8

Authors

More by this author
Role:
Author
ORCID:
0000-0003-1169-3431
More by this author
Role:
Author
ORCID:
0000-0001-7472-2039
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-1604-5353
More by this author
Role:
Author
ORCID:
0000-0003-2449-2516
More by this author
Role:
Author
ORCID:
0000-0002-1148-4747


Publisher:
Springer
Journal:
PharmacoEconomics More from this journal
Publication date:
2025-11-10
DOI:
EISSN:
1179-2027
ISSN:
1170-7690


Language:
English
Pubs id:
2338366
UUID:
uuid_b86d3d8d-df65-4d30-bdeb-e43c0875121d
Local pid:
pubs:2338366
Source identifiers:
W4416068433
Deposit date:
2025-12-01
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP